PBPIA

Pivotal bioVenture Partners Investment Advisor Portfolio holdings

AUM $161M
1-Year Est. Return 58.57%
This Quarter Est. Return
1 Year Est. Return
+58.57%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$124M
AUM Growth
-$24.5M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
11
New
Increased
Reduced
Closed

Top Buys

1 +$10.7M
2 +$261K

Top Sells

No sells this quarter

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OCS icon
1
Oculis Holding
OCS
$1.14B
$43.8M 35.43%
2,300,774
+563,078
ARQT icon
2
Arcutis Biotherapeutics
ARQT
$2.5B
$33.2M 26.84%
2,120,508
PCVX icon
3
Vaxcyte
PCVX
$5.5B
$26.8M 21.72%
710,734
+6,900
ZBIO
4
Zenas BioPharma
ZBIO
$1.13B
$5.82M 4.71%
736,645
INZY
5
DELISTED
Inozyme Pharma
INZY
$4.09M 3.31%
4,494,851
RXRX icon
6
Recursion Pharmaceuticals
RXRX
$2.56B
$3.15M 2.55%
595,518
BIOA
7
BioAge Labs
BIOA
$186M
$2.46M 1.99%
653,374
RLYB icon
8
Rallybio
RLYB
$22.4M
$1.56M 1.27%
2,404,644
VIGL
9
DELISTED
Vigil Neuroscience
VIGL
$998K 0.81%
560,595
IOBT icon
10
IO Biotech
IOBT
$43.2M
$942K 0.76%
864,197
BOLT icon
11
Bolt Biotherapeutics
BOLT
$11M
$757K 0.61%
94,573